Menotropin HMG 150iu Injection (Generic)

What is Menotropin HMG 150iu Injection (Generic)

Menotropin HMG 150iu Injection (Generic) is an injectable gonadotropin used in fertility care when the body needs extra follicle-stimulating hormone (FSH) and luteinizing hormone (LH) activity to support reproduction.

If you have been told your ovaries are not responding well to oral options, or you are preparing for assisted reproductive treatment, this medication is one of the standard tools clinics use to encourage controlled follicle growth.

What it is and how it works

Menotropin is made from human menopausal gonadotropins (often shortened to HMG). In practical terms, it provides FSH with LH activity. In women, FSH helps recruit and grow ovarian follicles, while LH activity supports hormone production inside the follicle as it matures. The goal is usually to help a follicle reach a size where ovulation can be triggered at the right time for intercourse, IUI, or egg retrieval in IVF.

In men, menotropins may be used in specific situations where stimulating the testes is the goal, typically under a specialist’s plan. It is not a general men’s health injection and is usually reserved for diagnosed fertility-related hormone conditions.

Who it is commonly prescribed for

• Ovulation induction for people who do not ovulate regularly.
• Controlled ovarian stimulation as part of IUI cycles.
• Controlled ovarian stimulation for IVF and related protocols.
• Selected cases of male infertility where gonadotropin therapy is appropriate.

How it is typically used in a cycle

Menotropin HMG is injected on a schedule set by your clinic. Dosing is measured in international units (IU) and is individualized. Many protocols use daily injections for several days, with adjustments based on ultrasound-observed follicle growth and blood hormone levels.

When follicles reach the intended stage, a separate medication is often used to trigger final maturation and to set the timing of ovulation. The treating clinic should determine exact timing and dosing, as small changes can meaningfully affect safety and outcomes.

Monitoring and why it matters

• Reduce the chance of ovarian hyperstimulation syndrome (OHSS).
• Lower the risk of releasing too many eggs in non-IVF cycles (which increases the chance of multiples).
• Decide when to adjust the dose, pause, or proceed with the next step.

Side effects and safety considerations

Some side effects are related to ovarian stimulation itself, not just the injection. People commonly report injection-site discomfort, headache, bloating, breast tenderness, nausea, or mood changes. Ovarian cysts can occur.

More serious risks can include OHSS, blood clots, severe pelvic pain from ovarian enlargement or torsion, allergic reactions, and complications related to multiple pregnancy. Seek urgent medical care for severe abdominal pain, rapid weight gain, shortness of breath, fainting, or leg swelling.

This medication is not appropriate for everyone. Your prescriber should screen for conditions such as uncontrolled thyroid or adrenal disorders, certain tumors, unexplained vaginal bleeding, and certain reproductive organ cancers. In women, it is not used when there is primary ovarian failure (ovaries cannot respond).

Available strengths

• ZyHMG 150iu Injection (Menotrophin (HMG))
• IVFhMG 75iu (Menotrophin [HMG])

Alternatives

• Menopur (menotropins): a widely used brand version of HMG.
• Recombinant FSH options: follitropin alfa (Gonal-f), follitropin beta (Follistim).
• Urinary FSH products (availability varies): urofollitropin preparations.
• LH support options in certain protocols: lutropin alfa (Luveris).
• Trigger medications (not the same as HMG): hCG products (Pregnyl, Novarel) or choriogonadotropin alfa (Ovidrel).
• Oral ovulation induction options (for selected patients): letrozole, clomiphene citrate.

FAQs About Menotropin HMG 150iu Injection